1. bookVolumen 7 (2013): Heft 4 (August 2013)
Zeitschriftendaten
License
Format
Zeitschrift
eISSN
1875-855X
Erstveröffentlichung
01 Jun 2007
Erscheinungsweise
6 Hefte pro Jahr
Sprachen
Englisch
Open Access

Review article. Assessing clinical evidence of drug interactions between citrus juices and cyclosporine

Online veröffentlicht: 04 Feb 2017
Volumen & Heft: Volumen 7 (2013) - Heft 4 (August 2013)
Seitenbereich: 477 - 489
Zeitschriftendaten
License
Format
Zeitschrift
eISSN
1875-855X
Erstveröffentlichung
01 Jun 2007
Erscheinungsweise
6 Hefte pro Jahr
Sprachen
Englisch

1. Bowers LD. Therapeutic monitoring for cyclosporine: Difficulties in establishing a therapeutic window. Clin Biochem. 1991; 24:81-7.10.1016/0009-9120(91)90315-6DOI öffnenSearch in Google Scholar

2. Armstrong VW, Oellerich M. New developments in the immunosuppressive drug monitoring of cyclosporine, tacrolimus, and azathioprine. Clin Biochem. 2001 34:9-16.10.1016/S0009-9120(00)00175-2DOI öffnenSearch in Google Scholar

3. Nowack R. Review article: cytochrome P450 enzyme, and transport protein mediated herb-drug interactions in renal transplant patients: grapefruit juice, St John’s Wort - and beyond!. Nephrology (Carlton). 2008;13:337-47.10.1111/j.1440-1797.2008.00940.xDOI öffnenSearch in Google Scholar

4. Paine MF, Widmer WW, Pusek SN, Beavers KL, Criss AB, Snyder J, et al. Further characterization of a furanocoumarin-free grapefruit juice on drug disposition: studies with cyclosporine. Am J Clin Nutr. 2008; 87:863-71.10.1093/ajcn/87.4.863Search in Google Scholar

5. Guo L-Q, Fukuda K, Ohta T, Yamazoe Y. Role of Furanocoumarin Derivatives on Grapefruit Juice- Mediated Inhibition of Human CYP3A Activity. Drug Metab Dispos. 2000; 28:766-71.Search in Google Scholar

6. Fukuda K, Ohta T, Yamazoe Y. Grapefruit component interacting with rat and human P450 CYP3A: possible involvement of non-flavonoid components in drug interaction. Biol Pharm Bull. 1997; 20:560-4.10.1248/bpb.20.560DOI öffnenSearch in Google Scholar

7. Fukuda K, Ohta T, Oshima Y, Ohashi N, Yoshikawa M, Yamazoe Y. Specific CYP3A4 inhibitors in grapefruit juice: furocoumarin dimers as components of drug interaction. Pharmacogenetics. 1997; 7:391-6.10.1097/00008571-199710000-00008DOI öffnenSearch in Google Scholar

8. He K, Iyer KR, Hayes RN, Sinz MW, Woolf TF, Hollenberg PF. Inactivation of Cytochrome P450 3A4 by Bergamottin, a Component of Grapefruit Juice. Chem Res Toxicol. 1998; 11:252-9.10.1021/tx970192kDOI öffnenSearch in Google Scholar

9. Tassaneeyakul W, Guo L-Q, Fukuda K, Ohta T, Yamazoe Y. Inhibition Selectivity of Grapefruit Juice Components on Human Cytochromes P450. Archives of Biochemistry and Biophysics. 2000; 378:356-63.10.1006/abbi.2000.1835DOI öffnenSearch in Google Scholar

10. Edwards DJ, Bernier SM. Naringin and naringenin are not the primary CYP3A inhibitors in grapefruit juice. Life Sciences. 1996; 59:1025-30.10.1016/0024-3205(96)00417-1DOI öffnenSearch in Google Scholar

11. Honda Y, Ushigome F, Koyabu N, Morimoto S, Shoyama Y, Uchiumi T, et al. Effects of grapefruit juice and orange juice components on P-glycoproteinand MRP2-mediated drug efflux. Br J Pharmacol. 2004; 143:856-64.10.1038/sj.bjp.0706008157594115504753DOI öffnenSearch in Google Scholar

12. Lim S-L, Lim L-Y. Effects of citrus fruit juices on cytotoxicity and drug transport pathways of Caco-2 cell monolayers. Int J Pharm. 2006; 307:42-50.10.1016/j.ijpharm.2005.09.017DOI öffnenSearch in Google Scholar

13. Romiti N, Tramonti G, Donati A, Chieli E. Effects of grapefruit juice on the multidrug transporter Pglycoprotein in the human proximal tubular cell line HK-2. Life Sciences. 2004; 76:293-302.10.1016/j.lfs.2004.06.015DOI öffnenSearch in Google Scholar

14. Ohnishi A, Matsuo H, Yamada S, Takanaga H, Morimoto S, Shoyama Y, et al. Effect of furanocoumarin derivatives in grapefruit juice on the uptake of vinblastine by Caco-2 cells and on the activity of cytochrome P450 3A4. Br J Pharmacol. 2000; 130: 1369-77.10.1038/sj.bjp.0703433Search in Google Scholar

15. Takanaga H, Ohnishi A, Yamada S, Matsuo H, Morimoto S, Shoyama Y, et al. Polymethoxylated Flavones in Orange Juice Are Inhibitors of Pglycoprotein but Not Cytochrome P450 3A4. J Pharmacol Exp Ther. 2000; 293:230-6.Search in Google Scholar

16. Egashira K, Ohtani H, Itoh S, Koyabu N, Tsujimoto M, Murakami H, et al. Inhibitory effects of pomelo on the metabolism of tacrolimus and the activities of CYP3A4 and P-glycoprotein. Drug Metab Dispos. 2004; 32:828-33.10.1124/dmd.32.8.828DOI öffnenSearch in Google Scholar

17. Edwards DJ, Fitzsimmons ME, Schuetz EG, Yasuda K, Ducharme MP, Warbasse LH, et al. 6',7'- dihydroxybergamottin in grapefruit juice and seville orange juice: effects on cyclosporine disposition, enterocyte CYP3A4, and p-glycoprotein. Clin Pharmacol Ther. 1999; 65:237-44.10.1016/S0009-9236(99)70102-5DOI öffnenSearch in Google Scholar

18. Malhotra S, Bailey DG, Paine MF, Watkins PB. Seville orange juice-felodipine interaction: Comparison with dilute grapefruit juice and involvement of furocoumarins[ast]. Clin Pharmacol Ther. 2001; 69: 14-23.10.1067/mcp.2001.11318511180034DOI öffnenSearch in Google Scholar

19. Hou Y-C, Hsiu S-L, Tsao C-W, Wang Y-H, Chao P-DL. Acute incation of toxication of cyclosporin caused by coadministration of decoctions of the fruits of Citrus aurantium and the pericarps of Citrus grandis. Planta Med. 2000; 66:653-5.10.1055/s-2000-862211105574DOI öffnenSearch in Google Scholar

20. Grenier J, Fradette C, Morelli G, Merritt GJ, Vranderick M, Ducharme MP. Pomelo juice, but not cranberry juice, affects the pharmacokinetics of cyclosporine in humans. Clin Pharmacol Ther. 2006; 79:255-62.10.1016/j.clpt.2005.11.01016513449DOI öffnenSearch in Google Scholar

21. Castillo JREd, Elsener J, Martineau GP. Pharmacokinetic modeling of in-feed tetracyclines in pigs using a meta-analytic compartmental approach. Swine Health Prod. 1998; 6:189-202.Search in Google Scholar

22. Bistrup C, Nielsen FT, Jeppesen UE, Dieperink H. Effect of grapefruit juice on Sandimmun Neoral(R) absorption among stable renal allograft recipients. Nephrol Dial Transplant. 2001; 16:373-7.10.1093/ndt/16.2.37311158415Search in Google Scholar

23. Herlitz H, Edgar B, Hedner T, Lidman K, Karlberg I. Grapefruit juice: a possible source of variability in blood concentration of cyclosporin A. Nephrol Dial Transplant. 1993; 8:375.Search in Google Scholar

24. Min DI, Ku YM, Perry PJ, Ukah FO, Ashton K, Martin MF, et al. Effect of grapefruit juice on cyclosporine pharmacokinetics in renal transplant patients. Transplantation Proceedings. 1996; 62: 123-5.10.1097/00007890-199607150-000238693526DOI öffnenSearch in Google Scholar

25. Proppe DG, Hoch OD, McLean AJ, Visser KE. Influence of chronic ingestion of grapefruit juice on steady-state blood concentrations of cyclosporine A in renal transplant patients with stable raft function. Br J Clin Pharmacol. 1995; 39:337-8.10.1111/j.1365-2125.1995.tb04459.xDOI öffnenSearch in Google Scholar

26. Proppe DG, Visser KE, Bartels R, Hoch OD, Meyer H, McLean AJ. Grapefruit juice selectively modifies cyclosporin A metabolite patterns in renal transplant patients. Clinic Pharmacol Ther. 1996; 59:138.10.1038/sj.clpt.1996.50DOI öffnenSearch in Google Scholar

27. Ducharme MP, Provenzano R, Dehoorne-Smith M, Edwards DJ. Trough concentrations of cyclosporine in blood following administration with grapefruit juice. Br J Clin Pharmacol. 1993; 36:457-9.10.1111/j.1365-2125.1993.tb00395.xDOI öffnenSearch in Google Scholar

28. Ducharme MP, Warbasse LH, Edwards DJ. Disposition of intravenous and oral cyclosporine after administration with grapefruit juice. Clin Pharmacol Ther. 1995; 57:485-91.10.1016/0009-9236(95)90032-2DOI öffnenSearch in Google Scholar

29. Ku YM, Min DI, Flanigan M. Effect of grapefruit juice on the pharmacokinetics of microemulsion cyclosporine and its metabolite in healthy volunteers: does the formulation difference matter?. J Clin Pharmacol. 1998; 38:959-65.10.1002/j.1552-4604.1998.tb04393.xDOI öffnenSearch in Google Scholar

30. Lee M, Min DI, Ku YM, Flanigan M. Effect of grapefruit juice on pharmacokinetics of microemulsion cyclosporine in African American subjects compared with Caucasian subjects: does ethnic difference matter? J Clin Pharm. 2001; 41:317-23.10.1177/00912700122010131DOI öffnenSearch in Google Scholar

31. Schwarz UI, Johnston PE, Bailey DG, Kim RB, Mayo G, Milstone A. Impact of citrus soft drinks relative to grapefruit juice on ciclosporin disposition. Br J Clin Pharmacol. 2005; 62:485-91.10.1111/j.1365-2125.2005.02519.xDOI öffnenSearch in Google Scholar

32. Yee GC, Stanley DL, Pessa LJ, Costa TD, Beltz SE, Ruiz J, et al. Effect of grapefruit juice on blood cyclosporin concentration. Lancet. 1995; 345:955-6.10.1016/S0140-6736(95)90700-9DOI öffnenSearch in Google Scholar

33. Brunner LJ, Pai KS, Munar MY, Lande MB, Olyaei AJ, Mowry JA. Effect of grapefruit juice on cyclosporin. A pharmacokinetics in pediatric renal transplant patients. Pediatr Transplant. 2000; 4:313-21.10.1034/j.1399-3046.2000.00136.xDOI öffnenSearch in Google Scholar

34. Hollander AA, van Rooij J, Lentjes GW, Arbouw F, van Bree JB, Schoemaker RC, et al. The effect of grapefruit juice on cyclosporine and prednisone metabolism in transplant patients. Clin Pharmacol Ther. 1995; 57:318-24.10.1016/0009-9236(95)90157-4DOI öffnenSearch in Google Scholar

35. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?. Controlled Clin Trials. 1996; 17: 1-12.10.1016/0197-2456(95)00134-4DOI öffnenSearch in Google Scholar

36. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315:629-34.10.1136/bmj.315.7109.629DOI öffnenSearch in Google Scholar

37. Begg CB, Mazumdar M. Operating Characteristics of a Rank Correlation Test for Publication Bias. Biometrics. 1994; 50:1088-101.10.2307/2533446DOI öffnenSearch in Google Scholar

38. Ameer B, Weintraub RA. Drug interactions with grapefruit juice. Clin Pharmacokinet. 1997; 33:103-21.10.2165/00003088-199733020-00003DOI öffnenSearch in Google Scholar

39. Bailey DG, Arnold JM, Spence JD. Grapefruit juice and drugs. How significant is the interaction? Clin Pharmacokinet. 1994; 26:91-8.10.2165/00003088-199426020-00002DOI öffnenSearch in Google Scholar

40. Dahan A, Altman H. Food-drug interaction: grapefruit juice augments drug bioavailability:mechanism, extent and relevance. Eur J Clin Nutr. 2004; 58:1-9.10.1038/sj.ejcn.1601736DOI öffnenSearch in Google Scholar

41. Haddad A, Davis M, Lagman R. The pharmacological importance of cytochrome CYP3A4 in the palliation of symptoms: review and recommendations for avoiding adverse drug interactions. Supportive Care Cancer. 2007; 15:251-7.10.1007/s00520-006-0127-5Search in Google Scholar

42. Hebert MF. Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery. Adv Drug Deliv Rev. 1997; 27:201-14.10.1016/S0169-409X(97)00043-4DOI öffnenSearch in Google Scholar

43. Huang S-M, Hall SD, Watkins P, Love LA, Serabjit- Singh C, Betz JM, et al. Drug Interactions with Herbal Products and Grapefruit Juice: A Conference Report[ast]. Clin Pharmacol Ther. 2004; 75:1-12.10.1016/j.clpt.2003.07.00214749688DOI öffnenSearch in Google Scholar

44. Ioannides C. Drug-phytochemical interactions. Inflammopharmacology. 2003; 11:7-42.10.1163/15685600332154710315035733DOI öffnenSearch in Google Scholar

45. Kane GC, Lipsky JJ. Drug-grapefruit juice interactions. Mayo Clin Proc. 2000; 75:933-42.10.4065/75.9.933DOI öffnenSearch in Google Scholar

46. Lo A, Burckart GJ. P-glycoprotein and drug therapy in organ transplantation. J Clin Pharmacol. 1999; 39: 995-1005.10.1177/00912709922011755DOI öffnenSearch in Google Scholar

47. Mertens-Talcott SU, Zadezensky I, De Castro WV, Derendorf H, Butterweck V. Grapefruit-Drug Interactions: Can Interactions With Drugs Be Avoided?. J Clin Pharmacol. 2006; 46:1390-416.10.1177/0091270006294277DOI öffnenSearch in Google Scholar

48. Schmidt LE, Dalhoff K. Food-drug interactions. Drugs [Review]. 2002; 62:1481-502.10.2165/00003495-200262100-00005Search in Google Scholar

49. Zhou SF, Lim LY, Chowbay B. Herbal modulation of P-glycoprotein. Drug Metab Rev. 2004; 36:57-104.10.1081/DMR-120028427DOI öffnenSearch in Google Scholar

50. Saito M, Hirata-Koizumi M, Matsumoto M, Urano T, Hasegawa R. Undesirable effects of citrus juice on the pharmacokinetics of drugs: Focus on recent studies. Drug Safety. 2006; 28:677-94.10.2165/00002018-200528080-00003DOI öffnenSearch in Google Scholar

51. Bailey DG. Sun drop citrus soda and cyclosporine interaction: comments on causality and recommendations. Transplant Proc. 2005; 79:747.10.1097/01.TP.0000148914.13844.D9DOI öffnenSearch in Google Scholar

52. Johnston A, Holt DW. Comment on: Lancet. 1995 Apr 15;345(8955):955-6. Effect of grapefruit juice on blood cyclosporin concentration. Lancet. 1995; 346: 122-3.10.1016/S0140-6736(95)92146-XSearch in Google Scholar

53. Paine MF, Oberlies NH. Clinical relevance of the small intestine as an organ of drug elimination: drug-fruit juice interactions. Expert Opin Drug Metab Toxicol. 2007; 3:67-80.10.1517/17425255.3.1.6717269895Search in Google Scholar

54. Rodriguez-Proteau R, Mata JE, Miranda CL, Fan Y, Brown JJ, Buhler DR. Plant polyphenols and multidrug resistance: effects of dietary flavonoids on drug transporters in Caco-2 and MDCKII-MDR1 cell transport models. Xenobiotica. 2006; 36:41-58.10.1080/0049825050043354516507512Search in Google Scholar

55. Fang SH, Hou YC, Hsiu SL, Chao PDL. Effects of Citrus grandis peels on cyclosporin concentration and immune responses in mice. J Food Drug Anal. 2006; 14:166-73.Search in Google Scholar

56. Wang M, Hou Y-C, Tsai S, Hsiu S-L, Wen K, Chao P-DL. Effects of coadministrations of unripe fruits and ripe peels of Citrus aurantium on cyclosporine pharmacokinetics in rats. JFDA. 2007; 15:265-70.Search in Google Scholar

57. Hou YC. Effects of citrus herbs on cyclosporin pharmacokinetics in rats and pigs (PDM-P-121). FIP World Congress. 2002; 62:48.Search in Google Scholar

58. Johnston PE, Milstone A. Probable interaction of bergamottin and cyclosporine in a lung transplant recipient. Transplant Proc. 2005; 79:746.10.1097/01.TP.0000148913.75002.33DOI öffnenSearch in Google Scholar

59. Mehrsai AR, Pourmand G, Mansour D, Zand S, Rezaali A. Effect of grapefruit juice on serum concentration of cyclosporine in Iranian renal transplant patients. Transplant Proc. 2003; 35: 2739-41.10.1016/j.transproceed.2003.08.080DOI öffnenSearch in Google Scholar

60. Sorkhi H, Moghadamnia AA, Oaliaee F, Pouramir M, Firoozjahi AR, Pasha AA, et al. Effect of tangerine juice on cyclosporine levels in renal transplant children. Pediatr Nephrol. 2008; 23:499-501.10.1007/s00467-007-0655-3DOI öffnenSearch in Google Scholar

61. Sorkhi H, Oliaei F, Moghadamnia AA, Pouramin M, Firoozjahi AR. Effect of Orange and Tangerine Juice on Cyclosporine Levels in Renal Transplant Recipients. Transplant Proc. 2007; 39:1228-30.10.1016/j.transproceed.2007.03.040DOI öffnenSearch in Google Scholar

62. Brunner LJ, Munar MY, Vallian J, Wolfson M, Stennett DJ, Meyer MM, et al. Interaction between cyclosporine and grapefruit juice requires long-term ingestion in stable renal transplant recipients. Pharmacotherapy. 1998; 18:23-9.Search in Google Scholar

63. Hermann M, Asberg A, Reubsaet JL, Sather S, Berg KJ, Christensen H. Intake of grapefruit juice alters the metabolic pattern of cyclosporin A in renal transplant recipients. Int J Clin Pharmacol Ther. 2002; 40:451-6.10.5414/CPP40451DOI öffnenSearch in Google Scholar

64. Emilia G, Longo G, Bertesi M, Gandini G, Ferrara L, Valenti C. Clinical Interaction Between Grapefruit Juice and Cyclosporine: Is There any Interest for the Hematologists?. Blood. 1998; 91:362-3.10.1182/blood.V91.1.362Search in Google Scholar

65. Akhlaghi F, Trull AK. Distribution of Cyclosporin in Organ Transplant Recipients. Clin Pharmacokinet. 2002; 41:615-37.10.2165/00003088-200241090-00001DOI öffnenSearch in Google Scholar

66. Fukuda K, Guo L, Ohashi N, Yoshikawa M, Yamazoe Y. Amounts and variation in grapefruit juice of the main components causing grapefruit-drug interaction. J Chromatogr B Biomed Sci Appl. 2000; 741:195-203.10.1016/S0378-4347(00)00104-3DOI öffnenSearch in Google Scholar

67. Friman S, Baeckman L. A new microemulsion formulation of cyclosporin: Pharmacokinetic and clinical features. Clin Pharmacokinet. 1996; 30:181-93.10.2165/00003088-199630030-000018882300DOI öffnenSearch in Google Scholar

68. Lohitnavy M, Lu Y, Lohitnavy O. A pharmacokinetic model of the gastrointestinal tract consisting of two segments can describe the concentration-time course of itraconazole. Int J Clin Pharmacol Ther. 2006; 44: 394-6.10.5414/CPP4439416961171DOI öffnenSearch in Google Scholar

69. Lohitnavy M, Lu Y, Lohitnavy O, Chubb LS, Hirono S, Yang RSH. A Possible Role of Multidrug Resistance- Associated Protein 2 (Mrp2) in Hepatic Excretion of PCB126, an Environmental Contaminant: PBPK/PD Modeling. Toxicol Sci. 2008; 104:27-39.10.1093/toxsci/kfn02618281255Search in Google Scholar

Empfohlene Artikel von Trend MD

Planen Sie Ihre Fernkonferenz mit Scienceendo